Year |
Citation |
Score |
2007 |
Buch SK, Khurdayan VK, Lutz SE, Knapp PE, El-Hage N, Hauser KF. Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro. Neuroscience. 146: 1546-54. PMID 17478053 DOI: 10.1016/J.Neuroscience.2007.03.006 |
0.542 |
|
2004 |
Khurdayan VK, Buch S, El-Hage N, Lutz SE, Goebel SM, Singh IN, Knapp PE, Turchan-Cholewo J, Nath A, Hauser KF. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. The European Journal of Neuroscience. 19: 3171-82. PMID 15217373 DOI: 10.1111/J.0953-816X.2004.03461.X |
0.545 |
|
2003 |
Hauser KF, Khurdayan VK, Goody RJ, Nath A, Saria A, Pauly JR. Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability. Cerebellum (London, England). 2: 184-95. PMID 14509568 DOI: 10.1080/14734220310016132 |
0.63 |
|
Low-probability matches (unlikely to be authored by this person) |
2006 |
Moral MA, Khurdayan VK, Bozzo J. Chronicles in drug discovery. Drug News & Perspectives. 19: 485-9. PMID 17160149 |
0.192 |
|
2005 |
Khurdayan VK, Bozzo J, Prous JR. Chronicles in drug discovery. Drug News & Perspectives. 18: 517-22. PMID 16391721 DOI: 10.1358/dnp.2005.18.8.953409 |
0.192 |
|
2005 |
Khurdayan V, Bozzo J, Sorbera L. Chronicles in drug discovery. Drug News & Perspectives. 18: 332-6. PMID 16193105 |
0.192 |
|
2005 |
Guitart X, Khurdayan VK. Highlights from the Fifth International Meeting on Metabotropic Glutamate Receptors, held September 18-23, 2005, in Taormina, Sicily, Italy. Metabotropic glutamate receptors as therapeutic targets. Drug News & Perspectives. 18: 587-93. PMID 16421632 |
0.16 |
|
2005 |
Guitart X, Khurdayan VK. Metabotropic glutamate receptor as therapeutic targets Drug News and Perspectives. 18: 587-593. |
0.156 |
|
2005 |
Khurdayan V, Davies S. Sequences in drug discovery. Drug News & Perspectives. 18: 197-201. PMID 15915221 |
0.151 |
|
2002 |
Thompson JS, Brown SA, Khurdayan V, Zeynalzadedan A, Sullivan PG, Scheff SW. Early effects of tribromoethanol, ketamine/xylazine, pentobarbitol, and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. Comparative Medicine. 52: 63-7. PMID 11900415 |
0.136 |
|
2005 |
Khurdayan V, Cullell-Young M. Chronicles in drug discovery. Drug News & Perspectives. 18: 277-80. PMID 16034484 |
0.131 |
|
2010 |
Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginès P, Bataller R. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells. Liver International : Official Journal of the International Association For the Study of the Liver. 30: 31-41. PMID 19929904 DOI: 10.1111/J.1478-3231.2009.02161.X |
0.126 |
|
2007 |
Khurdayan VK. Stem cells: therapeutic present and future. Timely Topics in Medicine. Cardiovascular Diseases. 11: E14. PMID 18297142 |
0.098 |
|
2007 |
Khurdayan VK. Stem cells: therapeutic present and future. Drug News & Perspectives. 20: 119-28. PMID 17440635 DOI: 10.1358/dnp.2007.20.2.1083433 |
0.098 |
|
2005 |
Sancho-Bru P, Bataller R, Gasull X, Colmenero J, Khurdayan V, Gual A, Nicolás JM, Arroyo V, Ginès P. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. Journal of Hepatology. 43: 272-82. PMID 15964095 DOI: 10.1016/J.Jhep.2005.02.035 |
0.097 |
|
2007 |
Khurdayan VK, Matito C. Profiling natural compounds: Focus on cancer Drugs of the Future. 32: 285-289. |
0.035 |
|
2007 |
Khurdayan VK. Take-home message: are we "off target"? Drug News & Perspectives. 20: 345-51. PMID 17878963 |
0.027 |
|
2007 |
Prous JR, Khurdayan VK. The story so far in R&D. Drug News & Perspectives. 20: 7-15. PMID 17332897 |
0.01 |
|
2007 |
Khurdayan V. Take-home message: 2007 American Society Of Clinical Oncology Annual Meeting Drugs of the Future. 32: 655-662. |
0.01 |
|
Hide low-probability matches. |